T. Cunningham

Discovery of an eIF4A Inhibitor with a Novel Mechanism of Action.

Derek J. Essegian, J. Schatz, S. Schürer, 2021, Journal of medicinal chemistry.

Paclitaxel synergizes with exposure time adjusted CD22-targeting immunotoxins against B-cell malignancies

I. Pastan, F. Müller, Tyler A. Cunningham, 2017, Oncotarget.

5-Azacytidine prevents relapse and produces long-term complete remissions in leukemia xenografts treated with Moxetumomab pasudotox

I. Pastan, M. Cam, Chin-Hsien Tai, 2018, Proceedings of the National Academy of Sciences.

Wide Variability in the Time Required for Immunotoxins to Kill B Lineage Acute Lymphoblastic Leukemia Cells: Implications for Trial Design

I. Pastan, A. Wayne, F. Müller, 2016, Clinical Cancer Research.

Proteomics reveal cap-dependent translation inhibitors remodel the translation machinery and translatome

J. Krieger, J. Schatz, J. Ho, 2021, Cell reports.

Domain II of Pseudomonas Exotoxin Is Critical for Efficacy of Bolus Doses in a Xenograft Model of Acute Lymphoblastic Leukemia

I. Pastan, R. Beers, T. Bera, 2018, Toxins.